Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2022; 12(4): 146-152


Heat shock protein-70 expression in CSCs tumor-associated macrophages induced by Typhonium flagelliforme tuber extract

Sugeng Ibrahim, Agung Putra, Nur Dina Amalina, Iqbal Pahlevi Adeputra Nasution.




Abstract
Cited by 5 Articles

One of the apoptotic resistance mechanisms in breast cancer stem cells (CSCs) is designed by the existence of tumorassociated macrophages (TAMs), type 2 macrophages. TAMs enhance the apoptotic resistance of CSCs by extremely decreasing low levels of inducible nitric oxide (iNO) and a reactive oxygen intermediate (ROI). On the other hand, heat shock protein-70 (Hsp-70) expression may modulate TAMs to upregulate those molecules. Typhonium flagelliforme (TF) tuber extract has an apoptotic activity through increasing iNO and ROI levels of cancer cells. However, the role of TF in increasing the Hsp-70 expression of TAMs leading to apoptosis improvement remains unclear. TAMs were produced by coculturing the human breast cancer-derived peripheral blood mononuclear cells with the CSCs. TAMs were assigned into two treatment groups consisting of one treatment group (treated by TF at 50.89 μg/ml) and the control group (medium administration only). The expression of Hsp-70 was analyzed by immunocytochemistry. This study found that Hsp-70 expression was shown to be significantly increased in TAMs. In conclusion, TF may promote the increase of Hsp-70 expression in TAMs. Hsp-70 as a promising drug target in cancer therapy for reducing resistance to cancer therapy has the potential to be developed and investigated further.

Key words: apoptosis resistance, CSCs, Hsp70, TAM, Typhonium flagelliforme.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.